Late adverse events in patients with pelvic cancer after oncologic treatment -intervention and treatment effect

Autor: Sofia Iselius, Annica Holmqvist, Rasmus Mikiver, Srinivas Uppugunduri
Rok vydání: 2022
DOI: 10.21203/rs.3.rs-2248214/v1
Popis: Purpose Few studies have focused on the late adverse events after oncologic treatment in pelvic cancer patients. Here, the treatment effect/interventions were studied on late side effects as GI, sexual and urinary symptoms in pelvic cancer patients who visited a highly specialized rehabilitation clinic in Linköping. Methods This retrospective longitudinal cohort study included 90 patients who had at least one visit at the rehabilitation clinic for late adverse events at Linköping University hospital between 2013 to 2019. The toxicity of the adverse events was analyzed by using the common terminology criteria for adverse events (CTCAE). Results By comparing the toxicity of symptoms between visit 1 and 2, we showed that the GI symptoms decreased with 36.6% (P = 0.013), the sexual symptoms with 18.3% (P P = 0.004). Patients who received bile salt sequestrant had a significant improvement in grade of GI symptoms as diarrhea/fecal incontinence at visit 2 compared to visit 1 where 91.3% were shown to have a treatment effect (P = 0.0034). The sexual symptoms (vaginal dryness/pain) significantly improved due to local estrogens between visit 1 and 2 where 58.1% had a reduction of symptoms (P = 0.0026). Conclusion The late side effects as GI, sexual and urinary symptoms was significantly reduced between visit 1 and 2 at the specialized rehabilitation center in Linköping. Bile salt sequestrants and local estrogens are effective treatments for side effects as diarrhea and vaginal dryness/pain.
Databáze: OpenAIRE